These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1155986)

  • 1. Pharmacokinetic rationale for a malarial suppressant administered once monthly.
    Peck CC; Lewis AN; Joyce BE
    Ann Trop Med Parasitol; 1975 Jun; 69(2):141-5. PubMed ID: 1155986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
    Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Kanjanapipatkul K; Doberstyn EB; Suebsaeng L
    Bull World Health Organ; 1985; 63(3):597-602. PubMed ID: 3899396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects.
    Sarikabhuti B; Keschamrus N; Noeypatimanond S; Weidekamm E; Leimer R; Wernsdorfer W; Kölle EU
    Acta Trop; 1988 Sep; 45(3):217-24. PubMed ID: 2903623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti.
    Nguyen-Dinh P; Payne D; Teklehaimanot A; Zevallos-Ipenza A; Day MM; Duverseau YT
    Bull World Health Organ; 1985; 63(3):585-92. PubMed ID: 3899394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
    Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
    Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro.
    Hellgren U; Kihamia CM; Bergqvist Y; Lebbad M; Premji Z; Rombo L
    Trans R Soc Trop Med Hyg; 1990; 84(4):469-72. PubMed ID: 2091329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
    Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
    Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
    Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
    Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose therapy of Falciparum malaria using pyrimethamine in combination with diformyldapsone or sulfadoxine.
    Doberstyn EB; Hall AP; Vetvutanapibul K; Sonkon P
    Am J Trop Med Hyg; 1976 Jan; 25(1):14-9. PubMed ID: 769572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone.
    Doberstyn EB; Teerakiartkamjorn C; Andre RG; Phintuyothin P; Noeypatimanondh S
    Trans R Soc Trop Med Hyg; 1979; 73(1):15-7. PubMed ID: 375485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum folate among persons taking Fansidar (pyrimethamine plus sulfadoxine) for prophylaxis of malaria.
    Stürchler D; Holzer B
    Acta Trop; 1980 Sep; 37(3):243-8. PubMed ID: 6106361
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro sensitivity of Plasmodium falciparum to sulfadoxine and pyrimethamine.
    Klinkaewnarong W; Chongsuphajaisiddhi T; Sabchareon A; Brockelman CR
    Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):296-301. PubMed ID: 3906921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.
    Hall AP; Doberstyn EB; Mettaprakong V; Sonkom P
    Br Med J; 1975 Apr; 2(5961):15-7. PubMed ID: 1093610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falciparum malaria resistant to Fansidar (sulphadoxine-pyrimethamine) occurring in three children of the same family.
    Ponnampalam JT
    Singapore Med J; 1982 Feb; 23(1):37-8. PubMed ID: 7051329
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
    Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
    Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
    Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant malaria.
    Lancet; 1981 Nov; 2(8255):1087-8. PubMed ID: 6118530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.